CDEK
by
Data4ThePeople
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
Sign in
Sign up
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
← All drugs
Report issue
morolimumab
mAb
experimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
Blood group Rh(D) polypeptide
INHIBITOR
RHD inhibitor
Blood group Rh(D) polypeptide
(RHD)
↗
Chemistry & pharmacology
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No
Oral
No
Parenteral
No
Topical
No
Sources
ChEMBL
CHEMBL2109138 ↗
Also known as
morolimumab